CIK 0001603454 · Non-accelerated filer<br>Smaller reporting company
Celcuity Inc.
Sign in to watch- Ticker
- CELC
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 763-392-0767
- Business address
- 16305 36TH AVENUE N, SUITE 100, MINNEAPOLIS, MN, 55446
- Former names
- Celcuity LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-11 | NIGON RICHARD Director | Option exercise · Warrants (right to buy) | −3,245 | 0 | ||
| 2025-09-08 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +13,976 | $56.22 | $786K | 703,920 |
| 2025-09-08 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +151,524 | $56.22 | $8.5M | 7,207,272 |
| 2025-09-08 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +388 | $58.02 | $23K | 704,308 |
| 2025-09-08 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +4,212 | $58.02 | $244K | 7,211,484 |
| 2025-09-02 | Sullivan Brian F. Chief Executive Officer | Option exercise | +104,340 | $8.05 | $840K | 1,370,199 |
| 2025-09-02 | Sullivan Brian F. Chief Executive Officer | Option exercise · Warrants (right to buy) | −104,340 | 0 | ||
| 2025-08-18 | Hahne Vicky Chief Financial Officer | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2025-08-18 | Laing Lance G. Chief Science Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2025-08-18 | Sullivan Brian F. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2025-08-18 | Sullivan Brian F. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2025-07-28 | Dalvey David Director | Sale 10b5-1 | −3,137 | $44.36 | $139K | 6,188 |
| 2025-07-28 | Dalvey David Director | Sale 10b5-1 | −4,163 | $45.24 | $188K | 2,025 |
| 2025-07-28 | Dalvey David Director | Sale 10b5-1 | −2,025 | $46.05 | $93K | 0 |
| 2025-07-28 | Dalvey David Director | Sale 10b5-1 | −57,044 | $43.30 | $2.5M | 167,956 |
| 2025-07-28 | Dalvey David Director | Sale 10b5-1 | −22,377 | $44.36 | $993K | 145,579 |
| 2025-07-28 | Dalvey David Director | Sale 10b5-1 | −16,438 | $45.29 | $744K | 129,141 |
| 2025-07-28 | Dalvey David Director | Sale 10b5-1 | −4,141 | $46.05 | $191K | 125,000 |
| 2025-05-28 | Buller Richard E Director | Gift · Stock Option (right to buy) | −6,522 | 0 | ||
| 2025-05-28 | Buller Richard E Director | Gift · Stock Option (right to buy) | +6,522 | 6,522 |
Page 4 of 19 · 365 trades